Millions more to prioritise mental health research in Australia

Health Industry Hub | May 27, 2020 |
[Total: 1    Average: 4/5]

Medical News: The Australian Government is providing $20 million additional funding for research to improve mental health care and reduce suicide rates in Australia.

Almost half of Australians will experience a mental illness in their lifetimes and as we battle COVID-19 it’s more important than ever that we prioritise mental health.

Research on the Mental Health Impacts of COVID-19

The disruption to normal life caused by the COVID-19 pandemic and the required restrictions has had profound impacts on the mental health and wellbeing of many Australians.

The Government will therefore be providing $3 million for a new grants round under the $125 million MRFF Million Minds Mission, for rapid research to improve the national mental health system response to the impacts of the COVID-19 pandemic.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

This funding is for new research that will help better position our mental health system to be more effective in supporting Australians to manage their mental health and wellbeing, during and following the pandemic.

Applications for grants of up to $1 million will open on 1 June, with the research projects expected to deliver results within 12 to 18 months.

These research projects and the grant opportunity complement the Government’s broader efforts around mental health and suicide prevention, including the recently announced National Mental Health and Wellbeing Pandemic Response Plan.

Since 30th January, the Government has provided an additional approximately $500 million for mental health services and support, including $64 million for suicide prevention, $74 million for preventative mental health services, $48 million to support the pandemic response plan.

It also includes a significant proportion of the $669 million telehealth package to support MBS-subsidised treatments provided by GPs, psychologists, psychiatrists and other mental health professionals.

In alignment with the Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals. The initiative is supported by Medicines Australia, AusBiotech and ARCS Australia. Learn more.

$10.3 Million for Suicide Prevention Research

The Government is also investing $10.3 million to support three research projects to help reduce the rate of suicide in Australia.

In 2018, suicide was responsible for 12.1 deaths per 100,000 people in Australia, with 3,048 suicides recorded in that year.

Every suicide is a tragedy and devastates families, friends and loved ones.

Through the Million Minds Mental Health Research Mission, the Government is investing in projects to better understand suicide and provide the right services, in the right place, at the right time.

The three successful projects to receive grants through the Mission are:

  • University of Melbourne (Professor Jane Pirkis): will receive $5.6 million to research the prevention of suicide in boys and men. Men account for 75 per cent of all suicides. This research will trial five interventions designed to encourage men to seek help. It will also trial two interventions designed to ensure that if men and boys seek help from telephone crisis support workers and psychologists, these providers can offer services that meet their needs.
  • University of New South Wales (Scientia Professor Helen Christensen AO): will receive $3.7 million for the Under the Radar Project. As many as 60 per cent of those who die by suicide are not in care. Many will only use the internet. This project will investigate the use of the internet as the first point of contact and develop a collaborative, consumer-led, comprehensive care model using digital, peer support and face-to-face services.
  • Murdoch Children’s Research Institute (Associate Professor Rebecca Giallo): will receive $951,000 to research suicide prevention among men in early fatherhood. One of the highest rates of suicide among men coincides with becoming fathers and raising young children. This project will develop effective interventions to improve men’s mental health during early fatherhood.

$6.75 Million to Improve Treatment Using Pharmacogenomics

In addition, the Government is investing $6.725 million to support research on the use of pharmacogenomics in providing more effective treatment options for Australians requiring medication for mental health challenges.

Pharmacogenomics looks at how genetics can affect a person’s response to certain drugs.

While psychological strategies are usually the first-line in treatment of mental illness, medications can be an important part of a treatment plan, with almost 10% of Australians now regularly taking antidepressants.

However, a significant number of people do not respond positively to their first prescription, causing delays in improvements to their symptoms and sometimes exacerbating anxiety.

Studies suggest that antidepressant treatment response is significantly influenced by each person’s specific genetic profile, and delays in improvement of symptoms can potentially be reduced through predictive pharmacogenomics testing.

This $6.75 million in funding, under the Medical Research Future Fund’s Emerging Priorities and Consumer Driven Research initiative, will allow four leading researchers to investigate how pharmacogenomics can be used to tailor mental health prescriptions to the needs of each individual and improve health outcomes.

The successful recipients are:

  • Professor Jon Emery (University of Melbourne) who will receive $1.39 million to investigate the effects of using pharmacogenomics to prescribe antidepressants on depression outcomes in patients with major depressive disorder in primary care.
  • Professor Sarah Medland (The Council of the Queensland Institute of Medical Research) who will receive $1.37 million to examine how we can improve the performance of pharmacogenomics in Australia.
  • Associate Professor Janice Fullerton (Neuroscience Research Australia) who will receive $1 million to investigate the pharmacogenomic signatures of bipolar disorder for improving treatment outcomes.
  • Doctor Kathy Wu (St Vincent’s Hospital Sydney) who will receive $2.95 million to conduct trial of genotype-guided versus standard psychotropic therapy in moderately-to-severely depressed patients.

Through record investments in mental health services and support, with expenditure estimated to be $5.2 billion this year alone, the Australian Government continues to demonstrate its firm commitment to the mental health and wellbeing of all Australians

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Private health insurer looking to invest in Australian private hospitals

Private health insurer looking to invest in Australian private hospitals

Health Industry Hub | July 15, 2020 |

MedTech News: In a recent opinion piece Dr Bill Coote, former AMA Secretary General and former Director of the Medicare […]


News & Trends - Pharmaceuticals

Pharma News - Merck Australia supports the first Australian-developed COVID-19 vaccine - Sypharma and Vaxine

Merck Australia supports the first Australian-developed COVID-19 vaccine

Health Industry Hub | July 15, 2020 |

Pharma News: Sypharma, an Australian biopharmaceutical formulation company, announced manufacturing of COVAX-19 and Advax adjuvant for Covid-19 in partnership with […]


News & Trends - Pharmaceuticals

Pharma News - Precision prescribing to combat Australia’s expected surge in mental illness

Precision prescribing to combat Australia’s expected surge in mental illness

Health Industry Hub | July 15, 2020 |

Pharma News: COVID-19 social isolation, familial and community disconnection, shock, job loss and health fears create the perfect storm for […]



Medical Pharma Biotech MedTech - $47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

$47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

Health Industry Hub | July 15, 2020 |

Medical News: The operation of the Australian Government’s $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular […]